Corticotroph tumour progression 37 years after bilateral adrenalectomy with temozolomide-naive response to pembrolizumab

Edward Mignone, Luke Ephraums, Ian Chapman, Esther Quick, Sunita M C De Sousa, Jui Ho · 2026

Read Corticotroph tumour progression 37 years after bilateral adrenalectomy with temozolomide-naive response to pembrolizumab by Edward Mignone, Luke Ephraums, Ian Chapman, Esther Quick, Sunita M C De Sousa, Jui Ho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615845.txt.

Description

Edward Mignone and co-authors report a pituitary tumour that grew again thirty-seven years after surgery, in a 2026 case paper. The patient had both adrenal glands removed for Cushing disease, a hormone disorder. Tumour growth after that surgery usually appears within ten years, so such a late return is among the latest recorded.

Profiling of the tumour showed an aggressive pattern, with several gene losses and gains and a growth index of ten percent. A marker that often predicts response to immune therapy was absent. Yet a checkpoint inhibitor drug, given for a separate skin cancer, brought a fast and lasting fall in hormone levels and tumour size. The authors draw three lessons: follow-up after adrenal surgery should last for life, profiling can guide care, and immune therapy may work even without that marker.

Catalog record

CREATOREdward Mignone, Luke Ephraums, Ian Chapman, Esther Quick, Sunita M C De Sousa, Jui Ho
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13615845

Browse the full library · About the Tower of Babel